{"title":"两党大力支持的药品定价“透明度”法案，但它能取得多大成效吗?","authors":"Stephen Barlas","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Several drug-price \"remedy\" bills are floating around Congress, with most being described as a \"first step.\" So why is no one referring to that step as significant?</p>","PeriodicalId":38773,"journal":{"name":"P and T","volume":"44 6","pages":"323"},"PeriodicalIF":0.0000,"publicationDate":"2019-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534173/pdf/ptj4406323.pdf","citationCount":"0","resultStr":"{\"title\":\"A Drug Pricing \\\"Transparency\\\" Bill With Strong Bipartisan Support But Would It Accomplish Much?\",\"authors\":\"Stephen Barlas\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Several drug-price \\\"remedy\\\" bills are floating around Congress, with most being described as a \\\"first step.\\\" So why is no one referring to that step as significant?</p>\",\"PeriodicalId\":38773,\"journal\":{\"name\":\"P and T\",\"volume\":\"44 6\",\"pages\":\"323\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534173/pdf/ptj4406323.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"P and T\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"P and T","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
A Drug Pricing "Transparency" Bill With Strong Bipartisan Support But Would It Accomplish Much?
Several drug-price "remedy" bills are floating around Congress, with most being described as a "first step." So why is no one referring to that step as significant?
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
